BAKNYSEIndustrial Organic ChemicalsFiscal year ends December 31

BRASKEM SA

Financials through fiscal 2025, year ended Dec 31, 2025

$1.70+0.04 (+2.41%)

Close on Oct 19, 2026

BRASKEM SA income statement

Millions of BRL, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31
Revenue	70,717	77,411	70,569	96,519	105,625	58,543	52,324	58,000	49,261	47,664	46,880
Cost of Revenue	69,161	71,414	67,548	85,161	73,568	47,331	45,879	46,577	36,177	34,986	36,698
Gross Profit	1,556	5,997	3,021	11,358	32,057	11,212	6,444	11,423	13,083	12,678	10,182
Research & Development	460	463	383	374	297	251	248	219	167	162	170
Selling, General & Admin	–	–	–	-5,285	-4,883	-4,077	-4,262	3,615	3,061	-2,851	-2,342
Selling & Marketing	2,067	1,991	1,916	2,108	2,056	1,852	1,783	1,689	1,446	1,404	1,077
General & Administrative	–	–	–	–	–	–	–	–	1,434	1,286	1,095
Operating Income	-1,807	-1,079	-2,792	4,272	26,044	-72	154	8,280	9,207	5,951	6,890
Interest Expense	6,802	6,853	5,589	5,066	4,903	4,913	3,883	3,008	3,747	3,571	3,163
Interest & Investment Income	2,290	1,719	1,678	1,374	1,581	600	851	589	604	690	585
Income from Equity Investments	9.00	-21	7.00	35	5.00	-19	10	-0.89	40	30	–
Pretax Income	-2,845	-17,733	-6,192	47	17,961	-9,684	-4,603	3,605	5,265	-140	4,414
Income Tax Expense	8,116	-5,681	-1,302	868	3,999	-2,668	-1,963	737	1,358	616	1,660
Income from Continuing Operations	–	–	–	–	–	-7,015	-2,640	2,868	3,907	-756	2,754
Income from Discontinued Operations	–	–	–	–	–	–	–	0	8.88	27	17
Net Income incl. Noncontrolling Interests	-10,961	-12,052	-4,890	-821	13,962	-7,015	-2,640	2,868	3,916	-729	2,760
Minority Interest in Earnings	-1,081	-732	-311	-485	-23	-324	-99	41	50	-318	-242
Net Income	-9,880	-11,320	-4,579	-336	13,985	-6,692	-2,541	2,828	3,865	-411	3,002
EPS (Basic)(per share)	–	–	–	–	17.57	-8.41	-3.19	3.55	4.85	-0.52	–
EPS (Diluted)(per share)	–	–	–	–	17.57	-8.41	-3.19	3.55	4.85	-0.52	–
Shares Outstanding (Basic, Weighted)(shares)	–	–	–	–	–	796	796	796	796	795	796,046
Shares Outstanding (Diluted, Weighted)(shares)	–	–	–	–	–	796	796	796	796	795	796,046
EBITDA	2,866	3,871	2,414	9,005	30,222	3,976	3,786	11,271	12,136	8,634	9,016

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin: 2.2%
Operating margin: -2.6%
Net margin: -14.0%
Return on equity, FY2025: 94.4%

Financial strength

Current ratio: 0.76
Debt to equity: -2.81
Debt to assets: 55.4%
Cash to current liabilities: 26.1%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.